Association between perinatal growth restriction and subsequent body build in very-low-birth-weight infants

Akinori Shichijo1, Keisuke Nakamura1, Hiroyuki Tomino1

  • 1Department of Pediatrics, National Hospital Organization, Saga National Hospital, Saga, Japan.

Insights

Perinatal growth restriction, including small for gestational age (SGA) and extrauterine growth restriction (EUGR), significantly impacts body build in very-low-birth-weight infants up to age nine. EUGR is linked to short stature and underweight, while SGA may increase overweight risk.

Area of Science:

  • Pediatrics
  • Growth and Development
  • Neonatology

Background:

  • Perinatal growth restriction affects long-term health outcomes in infants.
  • Understanding the impact of small for gestational age (SGA) and extrauterine growth restriction (EUGR) on body composition is crucial for very-low-birth-weight infants (VLBWIs).

Purpose of the Study:

  • To assess the influence of perinatal growth restriction (SGA and/or EUGR) on body build up to nine years of age in VLBWIs.
  • To identify specific growth restriction types associated with different body composition outcomes.

Main Methods:

  • Study included 283 VLBWIs categorized into four groups based on SGA and/or EUGR history.
  • Evaluated z-scores for height (zHT) and obesity index (OI), alongside prevalence of short stature, underweight, and overweight from age six to nine years.

Main Results:

  • Body height z-scores increased significantly, while obesity index remained unchanged.
  • Prevalence of underweight and overweight significantly increased, but short stature did not change.
  • Extrauterine growth restriction (EUGR) was associated with short stature and underweight, irrespective of SGA status.
  • Small for gestational age (SGA) was identified as a potential risk factor for being overweight, whereas EUGR was not.

Conclusions:

  • Perinatal growth restriction, particularly EUGR, significantly influences the body build of VLBWIs up to nine years old.
  • Different types of growth restriction have distinct associations with subsequent body composition and growth patterns.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.8K
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.9K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K